Enhance your mRNA production with market leading capping
By Trilink Thematic
Optimising mRNA production raises myriad questions for biomanufactures around how to navigate costs and maximise efficiency. TriLink BioTechnologies has leveraged its expertise to provide answers. Their CleanCap® M6 analog improves mRNA yields and boosts protein expression. With its newly optimised pulse-feed protocol, manufacturers can double production at just a fraction of the cost. As a proven solution in scalable IVT reactions, CleanCap® M6 ensures consistent quality and reduced costs for mRNA production. Download now to learn more.